EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AARS1‐mediated PHGDH lactylation promotes hepatocellular carcinoma progression by enhancing serine biosynthesis

Qing Zhu, Nanyan Yang, Xiangzhuo Miao, Shiting Xu, Junming Chen, Huohui Ou iD, Jianmin Nie, Pengyu Zhu, Yinghao Fang, Dinghua Yang iD

Clinical and Translational Medicine · 2026-11 · 16 (11)

DOI: 10.1002/ctm2.70899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 14.11.2026. Verfasst von Qing Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Hepatobiliary Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Phosphoglycerate Dehydrogenase, Serine. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The recently described lactyltransferase activity of alanyl‐tRNA synthetase 1 (AARS1) raises questions about its metabolic functions in hepatocellular carcinoma. We examined phosphoglycerate dehydrogenase (PHGDH) as a potential lactylation substrate linking AARS1 to serine metabolism and tumour growth.

Methods

Public expression data and patient tissues were studied alongside proteomic, lactylomic and targeted metabolomic profiles. Cellular and xenograft experiments used gene depletion, overexpression and reconstitution with wild‐type or mutant proteins. Immunoprecipitation and activity measurements assessed PHGDH regulation. Survival was examined with Kaplan‒Meier estimates and Cox regression, while experimental groups were compared by t ‐tests or analysis of variance.

Results

Of 140 paired specimens, 119 tumours (85%) had higher AARS1 mRNA than their non‐tumour counterparts. Elevated AARS1 independently predicted poorer survival, and E2F4 depletion lowered AARS1 expression. AARS1 supported malignant phenotypes, lactate production and PHGDH lactylation. Mass spectrometry detected lactylation at PHGDH‐K394. Relative to wild‐type PHGDH, K394R showed less lactylation and supported lower lysate enzyme activity, serine, glycine and glutathione levels. The mutant also increased reactive oxygen species, provided weaker phenotypic rescue and supported less xenograft growth. Depleting AARS1 reduced enzyme activity and malignant phenotypes in the wild‐type background; no further significant reduction was detected with K394R. β‐Alanine inhibited xenograft growth, but PHGDH‐K394 alone could not account for its effects.

Conclusions

AARS1‐associated PHGDH‐K394 lactylation may connect serine metabolism and redox regulation to hepatocellular carcinoma progression. Establishing therapeutic relevance will require site‐specific mechanistic experiments and additional preclinical validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPhosphoglycerate DehydrogenaseSerineHumansAnimalsMiceFemaleDisease ProgressionMaleCell Line, Tumor

Stichwörter der Autor:innen

alanyl‐tRNA synthetase 1hepatocellular carcinomalysine lactylationphosphoglycerate dehydrogenaseredox homeostasisserine metabolism

Substanzen

Phosphoglycerate DehydrogenaseSerine

Autor:innen und Institutionen

  • Unit of Hepatobiliary Surgery, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Thoracic Oncology and Surgery, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University,…
  • State Key Laboratory of Respiratory Disease, Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China.

ORCID-Profile: Huohui Ou, Dinghua Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhu, Q., Yang, N., Miao, X., Xu, S., Chen, J., Ou, H., Nie, J., Zhu, P., Fang, Y., & Yang, D. (2026). AARS1‐mediated PHGDH lactylation promotes hepatocellular carcinoma progression by enhancing serine biosynthesis. Clinical and Translational Medicine, 16(11). https://doi.org/10.1002/ctm2.70899

Vancouver

Zhu Q, Yang N, Miao X, Xu S, Chen J, Ou H, et al. AARS1‐mediated PHGDH lactylation promotes hepatocellular carcinoma progression by enhancing serine biosynthesis. Clinical and Translational Medicine. 2026;16(11). doi:10.1002/ctm2.70899

BibTeX
@article{Zhu2026,
  author = {Zhu, Qing and Yang, Nanyan and Miao, Xiangzhuo and Xu, Shiting and Chen, Junming and Ou, Huohui and Nie, Jianmin and Zhu, Pengyu and Fang, Yinghao and Yang, Dinghua},
  title = {AARS1‐mediated PHGDH lactylation promotes hepatocellular carcinoma progression by enhancing serine biosynthesis},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {11},
  doi = {10.1002/ctm2.70899}
}
Kostenlos starten →